SOURCE: Threshold Pharmaceuticals

Threshold Pharmaceuticals

October 06, 2011 06:00 ET

Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Oct 6, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 2011 BioCentury NewsMakers in the Biotech Industry Conference in New York City on Friday, October 21, 2011 at 11:00 AM EDT.

A live webcast of the presentation will be available under the Webcast section of the Company's Website at

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website (

Contact Information

  • Contact:
    Joel A. Fernandes
    Threshold Pharmaceuticals, Inc.
    Email Contact